2-acylaminothiazole derivative or salt thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S326000, C514S336000, C514S318000, C544S359000, C546S209000, C546S193000, C546S207000, C546S268100

Reexamination Certificate

active

10564520

ABSTRACT:
2-Acylaminothiazole derivatives or salts thereof which have a platelet increasing activity based on an excellent human c-mpl-Ba/F3 cell growth function and a function of accelerating formation of megakaryocytic colonies and which are useful for treating thrombocytopenia are provided.

REFERENCES:
patent: 5256675 (1993-10-01), Matsuo et al.
patent: 5369107 (1994-11-01), Matsuo et al.
patent: 5380736 (1995-01-01), Boigegrain et al.
patent: 2003/0195231 (2003-10-01), Hiroshi et al.
patent: 2004/0077697 (2004-04-01), Koshio et al.
patent: 2005/0153977 (2005-07-01), Sugasawa et al.
patent: 1 207 155 (2002-05-01), None
patent: 3-68567 (1991-03-01), None
patent: WO 01/07423 (2001-02-01), None
patent: WO 01/53267 (2001-07-01), None
patent: WO 02/062775 (2002-08-01), None
patent: WO 03/062233 (2003-07-01), None
International Search Report.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-acylaminothiazole derivative or salt thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-acylaminothiazole derivative or salt thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-acylaminothiazole derivative or salt thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3909098

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.